Rest easy, the FDA approval process for medical devices isn’t always a nightmare. Ventus Medical Inc. has won three FDA approvals in just a few years for its therapy for obstructive sleep apnea, or OSA. Now with solid results from a 250-patient trial in hand, President and CEO Peter Wyles is aiming not to convince the FDA to approve the therapy but doctors to prescribe it. Wyles spoke with San Francisco Business Times biotech reporter Ron Leuty about his company's strategy with the therapy, branded as Provent, the sleep apnea market, durable medical equipment distributors and doctors.
No comments:
Post a Comment